Bennetto-Hood C - Search Results

1

Novel methodology for antiretroviral quantitation in the female genital tract.

Bennetto-Hood C, Johnson VA, King JR, Hoesley CJ, Acosta EP. Bennetto-Hood C, et al. HIV Clin Trials. 2009 May-Jun;10(3):193-9. doi: 10.1310/hct1003-193. HIV Clin Trials. 2009. PMID: 19632958 Free PMC article.

2

Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.

Bennetto-Hood C, Bryson YJ, Stek A, King JR, Mirochnick M, Acosta EP. Bennetto-Hood C, et al. HIV Clin Trials. 2009 Jan-Feb;10(1):41-7. doi: 10.1310/hct1001-041. HIV Clin Trials. 2009. PMID: 19362995 Clinical Trial.

3

Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma.

Bennetto-Hood C, Long MC, Acosta EP. Bennetto-Hood C, et al. Rapid Commun Mass Spectrom. 2007;21(13):2087-94. doi: 10.1002/rcm.3056. Rapid Commun Mass Spectrom. 2007. PMID: 17546653

4

Persistence of nevirapine in breast milk after discontinuation of treatment.

Bennetto-Hood C, Aldrovandi GM, King JR, Woodman K, Ashouri N, Acosta EP. Bennetto-Hood C, et al. Clin Infect Dis. 2007 Aug 1;45(3):391-4. doi: 10.1086/519427. Epub 2007 Jun 18. Clin Infect Dis. 2007. PMID: 17599320

5

A sensitive HPLC-MS-MS method for the determination of raltegravir in human plasma.

Long MC, Bennetto-Hood C, Acosta EP. Long MC, et al. Among authors: bennetto hood c. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 May 15;867(2):165-71. doi: 10.1016/j.jchromb.2008.03.022. Epub 2008 Apr 1. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18430616

6

A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma.

Bennetto-Hood C, Tabolt G, Savina P, Acosta EP. Bennetto-Hood C, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jan 15;945-946:225-32. doi: 10.1016/j.jchromb.2013.11.054. Epub 2013 Dec 3. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 24361860 Free PMC article.

7

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age.

Rizk ML, Du L, Bennetto-Hood C, Wenning L, Teppler H, Homony B, Graham B, Fry C, Nachman S, Wiznia A, Worrell C, Smith B, Acosta EP. Rizk ML, et al. Among authors: bennetto hood c. J Clin Pharmacol. 2015 Jul;55(7):748-56. doi: 10.1002/jcph.493. Epub 2015 Apr 13. J Clin Pharmacol. 2015. PMID: 25753401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters